SARS-CoV-2 spike protein positivity in pityriasis rosea-like and urticaria-like rashes of COVID-19.

Welsh, E; Cardenas-de la Garza, J A; Cuellar-Barboza, A; Franco-Marquez, R; Arvizu-Rivera, R I

Welsh, E; Cardenas-de la Garza, J A; Cuellar-Barboza, A; Franco-Marquez, R; Arvizu-Rivera, R I.

Welsh E; Dermatology Service, Universidad Autónoma de Nuevo León, Hospital Universitario 'Dr José Eleuterio González', Monterrey, NL, México.
Cardenas-de la Garza JA; Rheumatology Department, Universidad Autónoma de Nuevo León, Hospital Universitario 'Dr José Eleuterio González', Monterrey, NL, México.
Cuellar-Barboza A; Dermatology Service, Universidad Autónoma de Nuevo León, Hospital Universitario 'Dr José Eleuterio González', Monterrey, NL, México.
Franco-Marquez R; Pathology Department, Universidad Autónoma de Nuevo León, Hospital Universitario 'Dr José Eleuterio González', Monterrey, NL, México.
Arvizu-Rivera RI; Internal Medicine Department, Universidad Autónoma de Nuevo León, Hospital Universitario 'Dr José Eleuterio González', Monterrey, NL, México.

Br J Dermatol ; 184(6): 1194-1195, 2021 06.

Article in English | MEDLINE | ID: covidwho-1054512

Subject(s)

COVID-19; Pityriasis Rosea; Urticaria; Humans; Pityriasis Rosea/diagnosis; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Urticaria/diagnosis

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Urticaria / Pityriasis Rosea / COVID-19 Type of study: Diagnostic study Limits: Humans Language: English Journal: Br J Dermatol Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google